Panel data analysis explores financial and economic factors impacting pharmaceutical stock returns, indicating predictive potential.
The fundamentals and macroeconomic factors can partially predict the risk and return of pharmaceutical companies.
No takes yet. Share an insight, caveat, or question.
Mojahedian et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: